Skip to content
Episode 3: Complex Innovative Trial Designs episode artwork

Jul 3, 2025 11 min

Episode 3: Complex Innovative Trial Designs

from QCast: Data-Driven Dialogue in Drug Development Hosted by Quanticate

In this QCast episode, join Jullia and Tom as they unpack Complex Innovative Trial Designs (CIDs), exploring how adaptive and Bayesian methods – from response-adaptive randomisation to platform protocols – are transforming clinical research by boosting efficiency, personalisation, and speed. Key Takeaways What makes a trial 'complex and innovative': adaptive rules, Bayesian borrowing, and seamless master protocols. Four CID categories: traditional adaptive, biomarker-guided, Bayesian borrowing, and platform vaccine trials. How CIDs deliver faster timelines, smaller sample sizes, and more ethical patient allocation. Essential preparation tips and guidelines for successful implementation. Common pitfalls to avoid, including under-powered designs, data integrity issues, and mismatched external controls. 🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & Management Biostatistics & Statistical Consultancy Statistical Programming & PK/PD Analysis Medical Writing & Pharmacovigilance Regulatory & Submission Support AI & Automation Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode details come from the podcast's RSS feed.

Embed this episode

In this QCast episode, join Jullia and Tom as they unpack Complex Innovative Trial Designs (CIDs), exploring how adaptive and Bayesian methods – from response-adaptive randomisation to platform protocols – are transforming clinical research by boosting efficiency, personalisation, and speed. Key Takeaways What makes a trial 'complex and innovative': adaptive rules, Bayesian borrowing, and seamless master protocols.Four CID categories: traditional adaptive, biomarker-guided, Bayesian borrowing...

Ready to play

Episode 3: Complex Innovative Trial Designs

0:00 11:24

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of QCast: Data-Driven Dialogue in Drug Development?

This episode is 11 minutes long.

When was this QCast: Data-Driven Dialogue in Drug Development episode published?

This episode was published on July 3, 2025.

Can I download this QCast: Data-Driven Dialogue in Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.